Association of Elevated Urinary Concentration of Renin-Angiotensin System Components and Severe AKI

被引:29
作者
Alge, Joseph L. [1 ]
Karakala, Nithin [1 ]
Neely, Benjamin A. [1 ]
Janech, Michael G. [1 ]
Tumlin, James A. [2 ]
Chawla, Lakhmir S. [3 ]
Shaw, Andrew D. [4 ,5 ]
Arthur, John M. [1 ,6 ]
机构
[1] Med Univ S Carolina, Charleston, SC 29425 USA
[2] Univ Tennessee, Coll Med Chattanooga, Chattanooga, TN USA
[3] George Washington Univ, Washington, DC USA
[4] Duke Univ, Durham, NC USA
[5] Durham Vet Affairs Med Ctr, Durham, NC USA
[6] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2013年 / 8卷 / 12期
基金
美国国家卫生研究院;
关键词
ACUTE KIDNEY INJURY; ACUTE-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; FACTOR-KAPPA-B; RIFLE CRITERIA; BIOMARKER; RISK; OUTCOMES; AXIS; CLASSIFICATION;
D O I
10.2215/CJN.03510413
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPrognostic biomarkers that predict the severity of AKI at an early time point are needed. Urinary angiotensinogen was recently identified as a prognostic AKI biomarker. The study hypothesis is that urinary renin could also predict AKI severity and that in combination angiotensinogen and renin would be a strong predictor of prognosis at the time of AKI diagnosis.Design, setting, participants, & measurementsIn this multicenter, retrospective cohort study, urine was obtained from 204 patients who developed AKI after cardiac surgery from August 2008 to June 1, 2012. All patients were classified as having Acute Kidney Injury Network (AKIN) stage 1 disease by serum creatinine criteria at the time of sample collection. Urine output was not used for staging. Urinary angiotensinogen and renin were measured, and the area under the receiver-operating characteristic curve (AUC) was used to test for prediction of progression to AKIN stage 3 or in-hospital 30-day mortality. These biomarkers were added stepwise to a clinical model, and improvement in prognostic predictive performance was evaluated by category free net reclassification improvement (cfNRI) and chi-squared automatic interaction detection (CHAID).ResultsBoth the urinary angiotensinogen-to-creatinine ratio (uAnCR; AUC, 0.75; 95% confidence interval [CI], 0.65 to 0.85) and the urinary renin-to-creatinine ratio (uRenCR; AUC, 0.70; 95% CI, 0.57 to 0.83) predicted AKIN stage 3 or death. Addition of uAnCR to a clinical model substantially improved prediction of the outcome (AUC, 0.85; cfNRI, 0.673), augmenting sensitivity and specificity. Further addition of uRenCR increased the sensitivity of the model (cfNRI(events), 0.44). CHAID produced a highly accurate model (AUC, 0.91) and identified the combination of uAnCR >337.89 ng/mg and uRenCR >893.41 pg/mg as the strongest predictors (positive predictive value, 80.4%; negative predictive value, 90.7%; accuracy, 90.2%).ConclusionThe combination of urinary angiotensinogen and renin predicts progression to very severe disease in patients with early AKI after cardiac surgery.
引用
收藏
页码:2043 / 2052
页数:10
相关论文
共 39 条
  • [1] Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit
    Alge, Joseph L.
    Karakala, Nithin
    Neely, Benjamin A.
    Janech, Michael G.
    Velez, Juan Carlos Q.
    Arthur, John M.
    [J]. CRITICAL CARE, 2013, 17 (02):
  • [2] Urinary Angiotensinogen and Risk of Severe AKI
    Alge, Joseph L.
    Karakala, Nithin
    Neely, Benjamin A.
    Janech, Michael G.
    Tomlin, James A.
    Chawla, Lakhmir S.
    Shaw, Andrew D.
    Arthur, John M.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (02): : 184 - 193
  • [3] Differential actions of renal ischemic injury on the intrarenal angiotensin system
    Allred, AJ
    Chappell, MC
    Ferrario, CM
    Diz, DI
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (04) : F636 - F645
  • [4] Losartan reverses fibrotic changes in cortical renal tissue induced by ischemia or ischemia-reperfusion without changes in renal function
    Barrilli, A
    Molinas, S
    Petrini, G
    Menacho, M
    Elías, MM
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 260 (1-2) : 161 - 170
  • [5] Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    Bellomo, R
    Ronco, C
    Kellum, JA
    Mehta, RL
    Palevsky, P
    [J]. CRITICAL CARE, 2004, 8 (04): : R204 - R212
  • [6] Acute kidney injury, mortality, length of stay, and costs in hospitalized patients
    Chertow, GM
    Burdick, E
    Honour, M
    Bonventre, JV
    Bates, DW
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11): : 3365 - 3370
  • [7] ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats
    da Silveira, Katia D.
    Bosco, Kenia S. Pompermayer
    Diniz, Lucio R. L.
    Carmona, Adriana K.
    Cassali, Giovanni D.
    Bruna-Romero, Oscar
    de Sousa, Lirlandia P.
    Teixeira, Mauro M.
    Santos, Robson A. S.
    Simoes e Silva, Ana C.
    Ribeiro Vieira, Maria A.
    [J]. CLINICAL SCIENCE, 2010, 119 (9-10) : 385 - 394
  • [8] Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)
    Endre, Zoltan H.
    Walker, Robert J.
    Pickering, John W.
    Shaw, Geoffrey M.
    Frampton, Christopher M.
    Henderson, Seton J.
    Hutchison, Robyn
    Mehrtens, Jan E.
    Robinson, Jillian M.
    Schollum, John B. W.
    Westhuyzen, Justin
    Celi, Leo A.
    McGinley, Robert J.
    Campbell, Isaac J.
    George, Peter M.
    [J]. KIDNEY INTERNATIONAL, 2010, 77 (11) : 1020 - 1030
  • [9] Angiotensin II, via AT1 and AT2 receptors and NF-κB pathway, regulates the inflammatory response in unilateral ureteral obstruction
    Esteban, V
    Lorenzo, O
    Rupérez, M
    Suzuki, Y
    Mezzano, S
    Blanco, J
    Kretzler, M
    Sugaya, T
    Egido, J
    Ruiz-Ortega, M
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06): : 1514 - 1529
  • [10] Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis
    Hall, Isaac E.
    Coca, Steven G.
    Perazella, Mark A.
    Eko, Umo U.
    Luciano, Randy L.
    Peter, Patricia R.
    Han, Won K.
    Parikh, Chirag R.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (12): : 2740 - 2749